The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 16822822)

Published in J Clin Endocrinol Metab on July 05, 2006

Authors

Gregory R Steinberg1, Andrew J McAinch, Michael B Chen, Paul E O'Brien, John B Dixon, David Cameron-Smith, Bruce E Kemp

Author Affiliations

1: St. Vincent's Institute, 9 Princes Street, Fitzroy, Victoria 3065, Australia. gsteinberg@svi.edu.au

Articles citing this

Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am J Physiol Endocrinol Metab (2009) 2.00

Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing. Int J Mol Sci (2009) 1.67

Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS One (2010) 1.64

Serum leptin level and cognition in the elderly: Findings from the Health ABC Study. Neurobiol Aging (2008) 1.59

Leptin in human physiology and therapeutics. Front Neuroendocrinol (2010) 1.46

Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes (2012) 1.20

Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol (2013) 1.17

Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS One (2012) 0.96

Fasting plasma leptin level is a surrogate measure of insulin sensitivity. J Clin Endocrinol Metab (2010) 0.95

Central obesity, leptin and cognitive decline: the Sacramento Area Latino Study on Aging. Dement Geriatr Cogn Disord (2012) 0.95

Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance. Diabetologia (2012) 0.94

Leptin, mild cognitive impairment, and dementia among elderly women. J Gerontol A Biol Sci Med Sci (2012) 0.92

Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6. PLoS One (2012) 0.92

Gender dimorphism in skeletal muscle leptin receptors, serum leptin and insulin sensitivity. PLoS One (2008) 0.92

Macropinocytosis is decreased in diabetic mouse macrophages and is regulated by AMPK. BMC Immunol (2008) 0.91

Role of AMP-activated protein kinase in the control of appetite. J Neuroendocrinol (2008) 0.89

Improved serum leptin and ghrelin following bariatric surgery predict better postoperative cognitive function. J Clin Neurol (2015) 0.83

Muscle hypertrophy and increased expression of leptin receptors in the musculus triceps brachii of the dominant arm in professional tennis players. Eur J Appl Physiol (2010) 0.83

Leptin signaling in skeletal muscle after bed rest in healthy humans. Eur J Appl Physiol (2013) 0.80

Regulation and function of AMPK in physiology and diseases. Exp Mol Med (2016) 0.80

Identification and saturable nature of signaling pathways induced by metreleptin in humans: comparative evaluation of in vivo, ex vivo, and in vitro administration. Diabetes (2014) 0.78

Antenatal glucocorticoid exposure enhances the inhibition of adrenal steroidogenesis by leptin in a sex-specific fashion. Am J Physiol Endocrinol Metab (2013) 0.78

Electroacupuncture inhibits weight gain in diet-induced obese rats by activating hypothalamic LKB1-AMPK signaling. BMC Complement Altern Med (2015) 0.78

Dynamic responses to leptin secretagogues in lean, obese, and massively obese men and women. Horm Res (2008) 0.77

Lack of exercise of "moderate to vigorous" intensity in people with low levels of physical activity is a major discriminant for sociodemographic factors and morbidity. PLoS One (2014) 0.75

Alantolactone Improves Prolonged Exposure of Interleukin-6-Induced Skeletal Muscle Inflammation Associated Glucose Intolerance and Insulin Resistance. Front Pharmacol (2017) 0.75

Articles by these authors

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA (2008) 13.69

AMPK in Health and Disease. Physiol Rev (2009) 6.38

The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem (2005) 6.27

Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med (2006) 5.54

Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA (2010) 4.33

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab (2010) 4.08

The ancient drug salicylate directly activates AMP-activated protein kinase. Science (2012) 3.77

AMPK is a direct adenylate charge-regulated protein kinase. Science (2011) 3.58

Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology (2007) 3.18

CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med (2006) 3.11

Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab (2008) 3.04

Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol (2006) 2.94

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes (2006) 2.80

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology (2004) 2.77

A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells (2003) 2.62

Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care (2002) 2.51

Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab (2006) 2.43

Preoxygenation is more effective in the 25 degrees head-up position than in the supine position in severely obese patients: a randomized controlled study. Anesthesiology (2005) 2.42

Systematic review of medium-term weight loss after bariatric operations. Obes Surg (2006) 2.37

Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes (2010) 2.35

Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest (2011) 2.34

β-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK). Proc Natl Acad Sci U S A (2010) 2.28

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) (2013) 2.22

Sentinel lymph node biopsy now has a limited role in melanoma management. Aust Fam Physician (2014) 2.19

AMPK beta subunit targets metabolic stress sensing to glycogen. Curr Biol (2003) 2.19

Health-related quality of life after renal denervation in patients with treatment-resistant hypertension. Hypertension (2012) 2.17

AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes (2008) 2.13

Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care (2009) 2.04

Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care (2009) 2.00

High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation (2009) 2.00

Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J Biol Chem (2003) 1.98

AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci U S A (2011) 1.96

Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J Biol Chem (2006) 1.93

Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. Chem Biol (2008) 1.93

Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med (2013) 1.91

Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise. Physiol Genomics (2004) 1.87

Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. Pharmacol Ther (2010) 1.82

Depression in association with severe obesity: changes with weight loss. Arch Intern Med (2003) 1.80

A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases. J Biol Chem (2003) 1.75

Weight loss and early and late complications--the international experience. Am J Surg (2002) 1.72

Adipocyte triglyceride lipase expression in human obesity. Am J Physiol Endocrinol Metab (2007) 1.69

The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg (2002) 1.64

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg Obes Relat Dis (2013) 1.60

Chutes and Ladders: the search for protein kinases that act on AMPK. Trends Biochem Sci (2005) 1.59

Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Diabetes (2003) 1.58

Minimal reporting requirements for weight loss: current methods not ideal. Obes Surg (2005) 1.58

Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J Biol Chem (2002) 1.56

Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am J Physiol Heart Circ Physiol (2002) 1.56

Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Circulation (2005) 1.55

General practice research--does gender affect the decision to participate? Aust Fam Physician (2012) 1.52

A reservoir of brown adipocyte progenitors in human skeletal muscle. Stem Cells (2008) 1.51

Regulation of 5'AMP-activated protein kinase activity and substrate utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab (2002) 1.51

Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci U S A (2008) 1.51

Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J Biol Chem (2001) 1.51

Structural basis for glycogen recognition by AMP-activated protein kinase. Structure (2005) 1.50

Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA (2012) 1.50

AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J Biol Chem (2009) 1.49

Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab (2005) 1.48

Does pregnancy increase the need for revisional surgery after laparoscopic adjustable gastric banding? Obes Surg (2011) 1.47

Sweet eating is not a predictor of outcome after Lap-Band placement. Can we finally bury the myth? Obes Surg (2002) 1.46

Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab (2005) 1.45

AMPK functions as an adenylate charge-regulated protein kinase. Trends Endocrinol Metab (2012) 1.44

Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type II muscle fibers. Am J Physiol Endocrinol Metab (2006) 1.44

Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice. Mol Cell Biol (2002) 1.43

Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site. Protein Sci (2004) 1.41

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract (2013) 1.40

Exercise increases nuclear AMPK alpha2 in human skeletal muscle. Diabetes (2003) 1.40

Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am J Physiol Endocrinol Metab (2002) 1.39

AMP-activated protein kinase beta subunit tethers alpha and gamma subunits via its C-terminal sequence (186-270). J Biol Chem (2005) 1.39

Systematic review of erosion after laparoscopic adjustable gastric banding. Obes Surg (2011) 1.36

Predicting sleep apnea and excessive day sleepiness in the severely obese: indicators for polysomnography. Chest (2003) 1.34

Aging and its effects on inflammation in skeletal muscle at rest and following exercise-induced muscle injury. Am J Physiol Regul Integr Comp Physiol (2010) 1.34

Loss of control is central to psychological disturbance associated with binge eating disorder. Obesity (Silver Spring) (2008) 1.34

A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg (2005) 1.32

Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance. Diabetes (2007) 1.32

Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. Obesity (Silver Spring) (2008) 1.31

Hunger control and regular physical activity facilitate weight loss after laparoscopic adjustable gastric banding. Obes Surg (2008) 1.31

Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity. J Biol Chem (2010) 1.30

AMP-activated protein kinase kinase: detection with recombinant AMPK alpha1 subunit. Biochem Biophys Res Commun (2002) 1.29

Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab (2004) 1.28

Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg (2002) 1.28

Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr (2006) 1.26

Docosapentaenoic acid (22:5n-3): a review of its biological effects. Prog Lipid Res (2010) 1.26

Short-term exercise training in humans reduces AMPK signalling during prolonged exercise independent of muscle glycogen. J Physiol (2005) 1.25

Reduced plasma FFA availability increases net triacylglycerol degradation, but not GPAT or HSL activity, in human skeletal muscle. Am J Physiol Endocrinol Metab (2004) 1.25

Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes (2012) 1.25

Regulation of the renal-specific Na+-K+-2Cl- co-transporter NKCC2 by AMP-activated protein kinase (AMPK). Biochem J (2007) 1.24